PNC Financial Services Group
KERX

PNC Financial Services Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

PNC Financial Services Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-168
Closed -$1K – 4304
2018
Q3 		$1K Buy
+168
New +$606 ﹤0.01% 4091
2016
Q3 		– Sell
-501
Closed -$3K – 4470
2016
Q2 		$3K Sell
501
-20
-4% -$112 ﹤0.01% 4091
2016
Q1 		$2K Buy
521
+18
+4% +$72 ﹤0.01% 4273
2015
Q4 		$3K Hold
503
– – ﹤0.01% 4085
2015
Q3 		$2K Sell
503
-168
-25% -$1.13K ﹤0.01% 4361
2015
Q2 		$7K Buy
671
+272
+68% +$2.92K ﹤0.01% 3968
2015
Q1 		$5K Buy
399
+135
+51% +$1.74K ﹤0.01% 4043
2014
Q4 		$4K Sell
264
-1,900
-88% -$29.4K ﹤0.01% 3621
2014
Q3 		$30K Buy
2,164
+1,900
+720% +$29.1K ﹤0.01% 2904
2014
Q2 		$4K Sell
264
-625
-70% -$8.86K ﹤0.01% 3391
2014
Q1 		$15K Buy
+889
New +$13.4K ﹤0.01% 2952

PNC Financial Services Group's KERX Position: Q4 2018 in Review

PNC Financial Services Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 168 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in KERX in Q1 2014 and held it in 11 quarters. The position peaked at $30K in Q3 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • PNC Financial Services Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 168 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $1K.
  • PNC Financial Services Group first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 11 quarters.
  • PNC Financial Services Group's Keryx Biopharmaceuticals Inc position peaked at $30K in Q3 2014.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on PNC Financial Services Group's 13F filing for Q4 2018, filed 8 Feb 2019.